CVI Holdings’s LumiraDx Limited Warrant LMDXW Stock Holding History

CVI Holdings’s Portfolio LMDXW Stock Details LMDXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-50,000	Closed	-$63K	–	1009
2021 Q3	$63K	Buy	+50,000	New	+$58K	﹤0.01%	722

Other funds holding LMDXW

CVS Health Woonsocket, Rhode Island $212M AUM 19.39% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Spring Creek Capital Wichita, Kansas $2.53B AUM 19.59% 1-Year Est. Return

Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Walleye Capital

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Integrity Capital Management (HK) Central, Hong Kong $64K AUM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

CVI Holdings's LMDXW Position: Q4 2021 in Review

CVI Holdings sold out of LumiraDx Limited Warrant (LMDXW) in Q4 2021, closing a stake of 50,000 shares — an estimated $63K sold.

CVI Holdings first reported a position in LMDXW in Q3 2021 and held it in 1 quarter. The position peaked at $63K in Q3 2021. 24 funds tracked by Wall St. Rank hold LMDXW as of Q4 2021.

CVI Holdings reported no remaining LumiraDx Limited Warrant position as of Q4 2021 after selling out during the quarter.
CVI Holdings sold 50,000 LumiraDx Limited Warrant shares in Q4 2021, an estimated $63K.
CVI Holdings first reported a position in LumiraDx Limited Warrant in Q3 2021 and held it in 1 quarter.
CVI Holdings's LumiraDx Limited Warrant position peaked at $63K in Q3 2021.
24 funds tracked by Wall St. Rank held LumiraDx Limited Warrant as of Q4 2021.

Based on CVI Holdings's 13F filing for Q4 2021, filed 14 Feb 2022.